Shinichiro Nakagawa

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients.

Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients.

Journal: Frontiers in immunology
Published: March 13, 2026

Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study.

Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study.

Journal: Frontiers in immunology
Published: February 05, 2025

Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy.

Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy.

Journal: Frontiers in immunology
Published: January 23, 2025

Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer.

Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer.

Journal: Cancers
Published: November 21, 2024

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine.

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine.

Journal: Frontiers in immunology
Published: May 16, 2023

Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.

Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.

Journal: Immunological investigations
Published: September 06, 2021

Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1.

Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1.

Journal: Blood
Published: August 17, 2021

Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.

Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.

Journal: Anticancer research
Published: May 22, 2021

A Case of Congenital Leukemia With MYB-GATA1 Fusion Gene in a Female Patient.

A Case of Congenital Leukemia With MYB-GATA1 Fusion Gene in a Female Patient.

Journal: Journal of pediatric hematology/oncology
Published: September 26, 2020

Factor X Deficiency with Heterozygous Mutations of Novel p.G435S and Known p.G244R in a Patient Presenting with Severe Umbilical Hemorrhage.

Factor X Deficiency with Heterozygous Mutations of Novel p.G435S and Known p.G244R in a Patient Presenting with Severe Umbilical Hemorrhage.

Journal: The Kurume medical journal
Published: March 18, 2017

Nanotherapy with hybrid liposomes for colorectal cancer along with apoptosis in vitro and in vivo.

Nanotherapy with hybrid liposomes for colorectal cancer along with apoptosis in vitro and in vivo.

Journal: Anticancer research
Published: September 10, 2014

Therapeutic effects of autologous lymphocytes activated with trastuzumab for xenograft mouse models of human breast cancer.

Therapeutic effects of autologous lymphocytes activated with trastuzumab for xenograft mouse models of human breast cancer.

Journal: Biological & pharmaceutical bulletin
Published: May 08, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026